U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

Mark One

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March~~September 3130, 2023

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to _______

Commission File No. 000-55260

MAKINGORG, INC.

(Exact name of registrant as specified in its charter)

Nevada

6770

39-2079723

(State or Other Jurisdiction of

Incorporation or Organization)

(Primary Standard Industrial

Classification Number)

(IRS Employer

Identification Number)

19th Floor, No. 9 Shangqingsi Road,Yuzhong District,

Chongqing, China

+86-023-6330810

(Address and telephone number of principal executive offices)

Securities registered pursuant to Section 12(b) of the Exchange Act:

None

Securities registered pursuant to Section 12(g) of the Exchange Act:

Common Stock, $0.001 par value

Indicate by checkmark whether the issuer: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-K (§229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-Q or any amendment to this Form 10-Q. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated ~~Filer~~filer ☐☒ Smaller reporting company ☒ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes ☐ No ☒

Applicable Only to Issuer Involved in Bankruptcy Proceedings During the Preceding Five Years. N/A

Indicate by checkmark whether the issuer has filed all documents and reports required to be filed by Section 12, 13 and 15(d) of the Securities Exchange Act of 1934 after the distribution of securities under a plan confirmed by a court. Yes ☐ No ☒

Applicable Only to Corporate Registrants

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the most practicable date:

Class	Outstanding as of July 124, 2024
Common Stock: $0.001	35,540,000

PART 1	FINANCIAL INFORMATION
Item 1	Consolidated Financial Statements (Unaudited)	3
	Balance Sheets	3
	Consolidated Balance Sheets	3
	Statements of Operations	4
	Consolidated Statements of Operations and Comprehensive Loss	4
	Statements of Change in Stockholders’ Deficit	5
	Consolidated Statements of Change in Stockholders’ Deficit	5
	Statements of Cash Flows	6
	Consolidated Statements of Cash Flows	6
	Notes to the Financial Statements	7
	Notes to the Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1514
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2119
Item 4.	Controls and Procedures	2119
PART II.	OTHER INFORMATION
Item 1	Legal Proceedings	2220
Item 1A	Risk Factors.	22
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	20
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	22
Item 3	Defaults Upon Senior Securities	20
Item 3	Defaults Upon Senior Securities	22
Item 4	Mine safety disclosures	20
Item 4	Mine safety disclosures	22
Item 5	Other Information	20
Item 5	Other Information	23
Item 6	Exhibits	21
Item 6	Exhibits	23
	Signatures	22
	Signatures	24

Table of Contents

PART I. ~~FINANCIAL INFORMATION~~

FINANCIAL INFORMATION

Item 1. Financial Statements.

MAKINGORG, INC. AND SUBSIDIARIES

~~CONDENSED~~ CONSOLIDATED BALANCE SHEETS

	March 31,2023			December 31,2022
	September 30,2023			December 31,2022
	(Unaudited)
ASSETS
Current Assets
Cash and cash equivalents	$	2743,~~129~~262		$	23,852
Accounts receivable – related party		-			32,334
Advances to vendors and others		41,544			41,314
Advances to vendor and others		13,551			41,314
Total Current Assets	$	6856,~~673~~813		$	97,500
Right-of-use assets - operating lease		60,751			24,587
Right-of-use assets - operating leases		43,116			24,587
Total Assets	$	~~129~~99,~~424~~929		$	122,087
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Interest payable	$	~~158~~170,000		$	152,000
Accrued liabilities		14,~~543~~336			17,109
Customer deposit – related party		3,640			-
Lease liabilities - operating leases		31,127			23,681
Lease liabilities - operating lease		32,273			23,681
Due to related party		387,918			387,918
Total Current Liabilities		~~583~~593,~~373~~381			580,708
Long-Term Liabilities
Long-term Liabilities
Convertible note payable, noncurrent	$	200,000		$	200,000
Convertible note payable	$	200,000		$	200,000
Lease liabilities - operating lease, non-current		31,269			5,501
Lease liabilities – Operating leases, noncurrent		13,941			5,501
Total Long-term Liabilities		231,269			205,501
Total Long-term liabilities		213,941			205,501
Total Liabilities	$	~~814~~807,~~642~~322		$	786,209
Commitment and Contingencies		-			-
Stockholders’ Equity (Deficit)
Stockholders’ Deficit
Preferred stock, par value $0.001; 50,000,000 shares authorized, zero shares issued and outstanding		-			-
Common stock, par value $0.001; 150,000,000 shares authorized, 35,540,000 shares issued and outstanding		35,540			35,540
Common stock, par value $0.001;150,000,000 shares authorized, 35,540,000 shares issued and outstanding		35,540			35,540
Additional paid-in capital		583,882			583,882
Accumulated other comprehensive loss		(47,~~640~~010	)		(4,882	)
Accumulated deficit		(1,~~300~~319,~~000~~805	)		(1,278,662	)
Total Stockholders’ Deficit		(~~685~~707,~~218~~393	)		(664,122	)
Total Liabilities and Stockholders’ Deficit	$	~~129~~99,~~424~~929		$	122,087

See accompanying notes to unaudited ~~condensed~~ consolidated financial statements.

Table of Contents

MAKINGORG, INC. AND SUBSIDIARIES

~~UNAUDITED CONDENSED~~ CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

	For the Three Months EndedMarch 31,
	2023			2022
Net Sales-Related Party	$	-		$	-
Cost of Sales		-			-
Gross Profit		-			-
OPERATING EXPENSES
Selling, general and administrative		6,233			23,960
Professional fees		9,110			17,593
TOTAL OPERATING EXPENSES		15,343			41,553
LOSS FROM OPERATIONS		(15,343	)		(41,553	)
OTHER INCOME (EXPENSE)
Interest income		4			-
Interest expense		(6,000	)		(6,000	)
Other income		1			2
TOTAL OTHER EXPENSE, NET		(5,995	)		(5,998	)
LOSS BEFORE INCOME TAX		(21,338	)		(47,551	)
Income tax		-			-
NET LOSS	$	(21,338	)	$	(47,551	)
OTHER COMPREHENSIVE ITEM:
Foreign currency translation Income		242			301
TOTAL COMPREHENSIVE LOSS	$	(21,096	)	$	(47,250	)
NET LOSS PER COMMON SHARE: BASIC AND DILUTED	$	(0.001	)	$	(0.001	)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC AND DILUTED		35,540,000			35,540,000

(Unaudited)

See accompanying notes to unaudited condensed consolidated financial statements.

	For the three months ended September 30,						For the nine months ended September 30,
	2023			2022			2023			2022
Net Sales-Related Party	$	93,375		$	39,507		$	105,433		$	39,507
Cost of Sales		(56,341	)		(31,862	)		(62,479	)		(31,862	)
Gross Profit		37,034			7,645			42,954			7,645

OPERATING EXPENSES
Selling, general and administrative		15,826			11,583			37,950			51,008
Professional fees		6,300			300			28,149			31,845
TOTAL OPERATING EXPENSES		22,126			11,883			66,099			82,853

INCOME(LOSS) FROM OPERATIONS		14,908			(4,238	)		(23,145	)		(75,208	)

OTHER INCOME (EXPENSE)
Interest income		-			15			1			117
Interest expense		(6,000	)		(6,000	)		(18,000	)		(18,000	)
Other income		-			121			1			121
TOTAL OTHER EXPENSES		(6,000	)		(5,864	)		(17,998	)		(17,762	)

INCOME(LOSS) BEFORE INCOME TAX		8,908			(10,102	)		(41,143	)		(92,970	)

Income tax		-			-			-			-

NET INCOME (LOSS)	$	8,908		$	(10,102	)	$	(41,143	)	$	(92,970	)

OTHER COMPREHENSIVE ITEM:
Foreign currency translation loss		(880	)		(6,040	)		(2,128	)		(13,145	)

TOTAL COMPREHENSIVE INCOME (LOSS)	$	8,028		$	(16,142	)	$	(43,271	)	$	(106,115	)

NET (INCOME) LOSS PER COMMON SHARE: BASIC AND DILUTED	$	0.000		$	(0.000	)	$	(0.001	)	$	(0.003	)

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC AND DILUTED		35,540,000			35,540,000			35,540,000			35,540,000

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

MAKINGORG, INC. AND SUBSIDIARIES

~~UNAUDITED~~ CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

	Three Months Ended March 31, 2023
							Accumulated
					Additional		Other						Total
	Common Stock				Paid-in		Comprehensive			Accumulated			Stockholders’
	Shares		Amount		Capital		Income (Loss)			Deficit			Deficit
Balance, December 31, 2022		35,540,000	$	35,540	$	583,882	$	(4,882	)	$	(1,278,662	)	$	(664,122	)
Foreign currency translation gain		-		-		-		242			-			242
Net loss		-		-		-		-			(21,338	)		(21,338	)
Balance, March 31, 2023		35,540,000	$	35,540	$	583,882	$	(4,640	)	$	(1,300,000	)	$	(685,218	)

(Unaudited)

	Three Months Ended March 31, 2022
							Accumulated
					Additional		Other						Total
	Common Stock				Paid-in		Comprehensive			Accumulated			Stockholders’
	Shares		Amount		Capital		Income (loss)			Deficit			Deficit
Balance, December 31, 2021		35,540,000	$	35,540	$	583,882	$	6,266		$	(1,162,307	)	$	(536,619	)
Foreign currency translation gain		-		-		-		301			-			301
Foreign currency translation loss		-		-		-		(13,145	)		-			(13,145	)
Net loss		-		-		-		-			(47,551	)		(47,551	)
Net loss for the nine months ended September 30, 2022		-		-		-		-			(92,970	)		(92,970	)
Balance, March 31, 2022		35,540,000	$	35,540	$	583,882	$	6,567		$	(1,209,858	)	$	(583,869	)
Balance, September 30, 2022		35,540,000	$	35,540	$	583,882	$	(6,809	)	$	(1,261,739	)	$	(649,126	)
Balance, December 31, 2022		35,540,000	$	35,540	$	583,882	$	(4,882	)	$	(1,278,662	)	$	(664,122	)
Foreign currency translation loss		-		-		-		(2,128	)		-			(2,128	)
Net loss for the nine months ended September 30, 2023		-		-		-		-			(41,143	)		(41,143	)
Balance, September 30, 2023		35,540,000	$	35,540	$	583,882	$	(7,010	)	$	(1,319,805	)	$	(707,393	)

See accompanying notes to unaudited ~~condensed~~ consolidated financial statements.

Table of Contents

MAKINGORG, INC. AND SUBSIDIARIES

~~UNAUDITED CONDENSED~~ CONSOLIDATED STATEMENTS OF CASH FLOWS

	For the Three Months Ended March 31,
	2023			2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(21,338	)	$	(47,551	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization of Right-of-use assets		(36,160	)		-
Changes in assets and liabilities:
Accounts receivable		32,649			-
Advances to vendors and others		-			(1,114	)
Interest payable		6,000			6,000
Accrued liabilities		(15,573	)		13,215
Lease liabilities		34,322			-
Customer deposit – related party		3,654			-
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES		3,554			(29,450	)
EFFECT OF EXCHANGE RATE CHANGES ON CASH		(277	)		133
NET CHANGE IN CASH AND CASH EQUIVALENTS		3,277			(29,317	)
Cash and cash equivalents, beginning of period		23,852			108,356
Cash and cash equivalents, end of period	$	27,129		$	79,039
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	$	-		$	-
Income taxes paid	$	-		$	-

(Unaudited)

See accompanying notes to unaudited condensed consolidated financial statements.

	For the nine months ended September 30,
	2023			2022

CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(41,143	)	$	(92,970	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization of Right-of-use assets		(20,372	)		(1,058	)
Lease Liabilities		17,871			96
Changes in assets and liabilities:
Accounts receivable – related party		31,785			(33,850	)
Advances to vendor and others		26,723			33,907
Interest payable		18,000			18,000
Accrued liabilities		(12,638	)		(586	)

CASH FLOW PROVIDED BY (USED IN) OPERATING ACTIVITIES		20,226			(76,461	)

CASH FLOWS FROM FINANCING ACTIVITIES
New loan from related party		-			1,500
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		-			1,500

EFFECT OF EXCHANGE RATE CHANGES		(816	)		(4,812	)

Net changes in cash and cash equivalents		19,410			(79,773	)
Cash and cash equivalents, beginning of periods		23,852			108,356
Cash and cash equivalents, end of periods	$	43,262		$	28,583

SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	$	-		$	-
Income taxes paid	$	-		$	-

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

~~MAKINGORG~~MakingORG, ~~INC~~Inc. ~~AND~~and ~~SUBSIDIARIES~~Subsidiaries

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

MakingORG, Inc. (“MakingORG”) was incorporated under the laws of the State of Nevada on August 10, 2012. The trading symbol is “CQCQ” and the fiscal year end is December 31. On October 20, 2016, MakingORG filed documents registering its intention to transact interstate business in the state of California. On November 29, 2016, MakingORG incorporated HK Feng Wang Group Limited (“HKFW”) under the laws of Hong Kong. On August 22, 2017, HKFW incorporated Chongqing Beauty Kenner Biotechnology Co., Ltd (“CBKB”) under the laws of the People’s Republic of China (“PRC”).

MaingORG, Inc. and its subsidiaries (“the Company”) purchase Acer truncatum bunge seed oil from China, outsource to third party to manufacture Acer truncatum bunge related health products, and sell to end users and distributors in the United States and PRC.

In January 2020, the World Health Organization declared an outbreak of the coronavirus (“COVID-19”) to be a Public Health Emergency of International Concern, subsequently declared COVID-19 a global pandemic, and recommended containment and mitigation measures worldwide on March 11, 2020. The Company experienced some adverse impacts on its business in the PRC Segment, such as limited access to its staff in the PRC and restrictions on business travel within the PRC and between USA and PRC. The pandemic created global economic uncertainties and led to negative impact on the financial markets. The extent of the COVID-19 impact to the Company depends on numerous factors and developments related to COVID-19. Consequently, the business of the Company dropped significantly in the past years. The federal COVID-19 Public Health Emergency declaration in the U.S. ended in May 2023, and COVID-19 restrictions have been lifted in many locations globally. We do not expect future material economic consequences from the COVID-19 pandemic.

NOTE 2 – GOING CONCERN

Pursuant to ASU 2014-15, the Company has assessed its ability to continue as a going concern for a period of one year from the date of the issuance of these consolidated financial statements. Substantial doubt about an entity’s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year from the financial statement issuance date. The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principle, which contemplate continuation of the Company as a going concern. The Company currently suffered recurring loss from operations, generated negative cash flow from operating activities and has an accumulated deficit and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. These conditions raise substantial doubt as to its ability to continue as a going concern. These consolidated financial statements do not include adjustments relating to the recoverability and classification of reported asset amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

The Company had a net losses ~~loss~~ of $2141,~~338~~143 ~~and $47,551~~ for the ~~three~~nine months ended ~~March~~September 3130, 2023 ~~and 2022, respectively~~. In addition, the Company had an accumulated ~~deficit~~deficits of $1,~~300~~319,~~000~~805 and $1,278,662 as of ~~March~~September 3130, 2023 and December 31, 2022, respectively. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent on its ability to raise additional capital. The Company’s consolidated financial statements do not include any adjustments relating to the recoverability and classification of reported asset amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Management anticipates that the Company will be dependent, in the near future, on additional investment capital to fund operating expenses. The Company may seek additional funding through issuance of additional common stock and/or borrowings from financial institutions or the majority shareholder to support its normal business operations. In light of management’s efforts, there is no assurance that the Company will be successful in this or any of its endeavors or become financially viable to continue as a going concern.

Table of Contents

Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses. The Company may seek additional funding through issuance of additional common stock and/or borrowings from financial institutions or the majority shareholder to support its normal business operations. There is no assurance that the Company will be successful in this or any of its endeavors or become financially viable to continue as a going concern.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s most recent Annual Financial Statements filed with the SEC on Form 10-K/A. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal period, as reported in ~~the Company’s~~ Form 10-K/A filed on October 23, 2023, have been omitted.

Principles of Consolidation

The Company’s unaudited ~~condensed~~ consolidated financial statements ~~refer~~include tothe accounts of MakingORG, ~~Inc.~~ and its wholly owned subsidiaries, HKFW and CBTB. All intercompany transactions and balances were eliminated in consolidation.

Use of Estimates

The preparation of unaudited ~~condensed~~ consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the Company’s unaudited ~~condensed~~ consolidated financial statement date and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.

8 Table of Contents

Revenue Recognition

The Company adopted Topic 606, Revenue from Contracts with Customers, using the modified retrospective transition method on January 1, 2018. In general, the Company’s performance obligation is to transfer itits products to its end user or distributor. Revenues from product sales are recognized when the customer obtains control of the Company’s finished goods product, which occurs at a point in time, typically upon delivery to the customer.

AsThe ~~of March 31, 2023 and 2022, the~~ Company’s ~~did not generate any~~ revenue~~. The~~ ~~Company~~mainly generates ~~revenue~~ from ~~sales~~the sale of acer truncatum -bunge -related health products, such as Nervonic Acid Oil, coffee and tea ~~by its wholly-owned subsidiary in China~~. The Company evaluated its product sales contracts and determined that those contracts are generally capable of being distinct and accounted for as separate performance obligations. Performance obligation is satisfied ~~when~~at ~~the~~point ~~finished~~of ~~goods~~time ~~product~~when products delivered to the customer.

Shipping and handling costs paid by the Company are included in the cost of sales.

Recently Issued Accounting Pronouncement Adopted

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses”. The standard, including subsequently issued amendments (ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10 and ASU 2019-11), requires a financial asset measured at amortized cost basis, such as accounts receivable and certain other financial assets, to be presented at the net amount expected to be collected based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. In November 2019, the FASB issued ASU No. 2019-10 to postpone the effective date of ASU No. 2016-13 for public business entities eligible to be smaller reporting companies defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted ASU No. 2016-13 effective on January 1, 2023. Adoption of the new standard did not have impact on the Company’s consolidated financial statements or financial disclosure since there was no accounts receivable balance as of January 1, 2023.

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (ASC 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, “Revenue from Contracts with Customers,” as if the acquirer had originated the contracts. Under current accounting standards, contract assets and contract liabilities acquired in a business combination are to be recorded at fair value using the ASC 805 measurement principle. ASU 2021-08 is effective for fiscal years and interim reporting periods within those fiscal years beginning after December 15, 2022. The adoption of ASU 2021-08, effective January 1, 2023, did not have an impact on the financial condition, results of operations, cash flows and disclosures of the Company.

Recently Issued Accounting Pronouncement Not Yet Adopted

Table of Contents

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amended guidance requires incremental reportable segment disclosures, primarily about significant segment expenses. The amendments also require entities with a single reportable segment to provide all disclosures required by these amendments, and all existing segment disclosures. The amendments will be applied retrospectively to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently in the process of evaluating the impact this amended guidance may have on the footnotes to its consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amended guidance enhances income tax disclosures primarily related to the effective tax rate reconciliation and income taxes paid information. This guidance requires disclosure of specific categories in the effective tax rate reconciliation and further information on reconciling items meeting a quantitative threshold. In addition, the amended guidance requires disaggregating income taxes paid (net of refunds received) by federal, state, and foreign taxes. It also requires disaggregating individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received). The amended guidance is effective for fiscal years beginning after December 15, 2024. The guidance can be applied either prospectively or retrospectively. The Company is currently in the process of evaluating the impact this amended guidance may have on the footnotes to our consolidated financial statements.

Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption.

9NOTE ~~Table~~4 of– ~~Contents~~ADVANCES TO VENDOR AND OTHERS

~~NOTE~~Advances 4to –vendor ~~ADVANCES~~and TOothers ~~VENDORS~~includes ~~AND~~primarily ~~OTHERS~~deposit for packaging materials. As of September 30, 2023 and December 31, 2022, advances to vendor and others were $13,551 and $41,314, respectively.

Advances to vendors and others include primarily deposit for packaging materials. As of March 31, 2023 and December 31, 2022, advances to vendors and others were $41,544 and $41,314, respectively.

NOTE 5 – RELATED PARTY TRANSACTIONS

Advance from Customer

As of March 31, 2023 and December 31, 2022, the Company advances from the customer was $3,640 and $0, respectively.

Loan from Related Party

For the nine months ended September 30, 2023 and 2022, the Company borrowed from the sole officer in the amounts of $0 and $1,500, respectively. As of ~~March~~September 3130, 2023 and December 31, 2022, the Company ~~was~~ obligated to the officer, for an unsecured, non-interest-bearing demand loan with a balance of $387,918 and $387,918, respectively.

Sales to Related Party

For the ~~three~~nine months ended ~~March~~September 3130, 2023 and 2022, ~~there~~net sales to Entity A were no$105,433 and $39,507, accounting for 100% of the sales ~~and~~the noCompany generated for the periods, respectively. The accounts receivable ~~due~~as toof ~~Covid-19~~September ~~regulations~~30, ~~affecting~~2023 ~~businesses~~and ~~operating~~December in31, ~~China~~2022 were $nil and $32,334, which accounted for 100% of the accounts receivable of the Company, respectively.

Lease Agreement

On March 1, 2022, the Company entered into a new lease agreement with Chongqing Fengpu Wanjia Biotechnology Co., Ltd for the same office location for the period from March 1, 2022 to February 28, 2023. ~~Pursuant to the lease agreement, monthly rent was lowered to RMB20,000 (approximately $3,200), payable by the 5th of each month with the first two-month rent free.~~ The ~~lease was for a one-year term and the~~ Company ~~had the priority to renew the lease. The Company~~ renewed the lease ~~and~~on ~~has been leasing the property since~~ February 28, 2023 for RMB20,000 per month. The lease expires on February 28, 2025. ~~Based~~See onNote ~~the~~8 ~~lease~~Lease ~~agreement,~~for ~~$60,571~~more ~~and~~information ~~$63,542~~about ~~right-of-use~~the ~~(“ROU”) assets and~~ lease ~~liabilities was recognized as of March 31, 2023, respectively~~.

109 Table of Contents

NOTE 6 – BUSINES CONCENTRATION AND RISKS

Concentration of Risk

The Company maintains cash with banks in the USA, People’s Republic of China (“PRC” or “China”), and Hong Kong. Should any bank holding cash become insolvent, or if the Company is otherwise unable to withdraw funds, the Company would lose the cash with that bank; however, the Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank accounts. In China, a depositor has up to RMB500,000 insured by the People’s Bank of China Financial Stability Bureau (“FSD”). In Hong Kong, a depositor has up to HKD500,000 insured by Hong Kong Deposit Protection Board (“DPB”). In the United States, the standard insurance amount is $250,000 per depositor in a bank insured by the Federal Deposit Insurance Corporation (“FDIC”).

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. As of ~~March~~September 3130, 2023 and December 31, 2022, $2743,~~129~~262 and $23,852 ~~balances~~ of the Company’s cash and cash equivalents, were all insured, respectively.

With respect to accounts receivable, the Company generally does not require collateral and does not have an allowance for doubtful accounts. No uncollectible accounts receivable in the past years.

Major customer

For the nine months ended September 30, 2023 and 2022, total sales to Entity A – the 100% customer, were $105,433 and $39,507, accounted for 100.0% of the sales the Company recognized, respectively. Accounts receivable due from Entity A were $0 and $32,334 as of September 30, 2023 and December 31, 2022, which accounted for 100.0% of the accounts receivable of the Company, respectively.

Major vendor

For the nine months ended September 30, 2023 and 2022, the Company purchased $62,479 and $31,862, respectively from one vendor. It accounted for 100.0% of total purchase of the Company for the nine months ended September 30, 2023 and 2022.

NOTE 7 – CONVERTIBLE NOTE PAYABLE

On September 1, 2016, the Company entered into a ~~Convertible~~convertible ~~Note~~note ~~Agreement~~agreement inwith the principal amount of $200,000 with an unrelated party ~~for two years~~. The note bears an interest atof 12% per annum and the holder is able to convert all unpaid interest and principal into common shares at $3.50 per share at the maturity date. The note matures on September 1, 2018. The Company recognized a discount on the note of $38,857 on the agreement date. The interest expense was due every six months commencing on March 1, 2017 until the principal amount of this convertible note is paid in full.

On September 1, 2018 and 2019, the Company entered into two Amended and Restated 12% Convertible Promissory Notes for one year with no consideration. The Company recognized a discount on the note of $40,000 and $54,000 aton the amended agreement dates, respectively. Since the conversion feature of conventional convertible debt provides for a rate of conversion that is below market value, this feature is characterized as a beneficial conversion feature (“BCF”). A BCF is recorded by the Company as a debt discount pursuant to ASC Topic 470-20 “Debt with Conversion and Other Options.” In those circumstances, the convertible debt is recorded net of the discount related to the BCF and the Company amortizes the discount to interest expense over the life of the debt using the effective interest method.

On10 ~~September~~Table 1,of ~~2020, the convertible note agreement was extended to September 1, 2022 with no additional consideration and no discount on the note.~~Contents

On September 1, 2020, the convertible note agreement was extended to September 1, 2022 with no additional consideration and no discount on the note. On September 1, 2022, the Company amended and restated the 12% convertible promissory note. Pursuant to the amended convertible promissory note, both parties agreed to extend the convertible note agreement to September 1, 2024 with no additional consideration and no discount on the note.

The Company recognized interest ~~expense~~expenses related to the convertible note of $618,000 and $618,000 for the ~~three~~nine months ended ~~March~~September 3130, 2023 and 2022, respectively. As of ~~March~~September 3130, 2023 and December 31, 2022, net balance of the convertible note amounted to $200,000 and $200,000, ~~respectively,~~ with $~~158~~170,000 and $152,000 interest payable, respectively.

NOTE 8 – LEASE

On March 1, 2022, the Company entered into a lease agreement with Chongqing Fengpu Wanjia Biotechnology Co., Ltd for the period from March 1, 2022 to February 28, 2023. Pursuant to the lease agreement, monthly rent was lowered to RMB20,000 (approximately $3,200), payable by the 5th of each month with the first two-month rent free. The lease was for a one-year term and the Company had ~~the~~ priority to renew the lease. The Company renewed the lease and has been leasing the property since February 28, 2023 for RMB20,000 per month. The lease expires on February 28, 2025. Leases is classified as operating at the inception of the lease and ROU assets and operating lease liabilities are recognized based on the present value of lease payments over the lease terms of the commencement date with 5.80% incremental borrowing rate used. The lease does not contain any residual value guarantees or material restrictive covenants.

11 Table of Contents

The components of lease expense consist of the following:

		Three Months Ended March 31,
		For the Nine MonthsEnded September 30,
	Classification	2023		2022
Operating lease cost	S,Operating ~~G&A~~ expense	$	219,~~801~~289	$	1519,~~227~~385
Net lease cost		$	219,~~801~~289	$	1519,~~227~~385

Table of Contents

Balance sheet information related to leases consists of the following:

Assets	Classification	~~March~~September 3130, 2023			December 31, 2022
Operating lease ROU assets	Right-of-use assets	$	6043,~~751~~116		$	24,587
Total leased assets		$	60,751		$	24,587
Total lease assets		$	43,116		$	24,587
Liabilities
Operating lease liabilities	~~Current portion~~	$	~~32,273~~		$	~~23,681~~
	Long-term portion		31,269			5,501
Short-term		$	31,127		$	236,811
Total lease liabilities		$	63,542		$	29,182
Long-term			13,941			5,501
Total lease liabilities		$	45,068		$	29,182
Weighted average remaining lease term
Operating leases			1.9242			1.17
Weighted average discount rate
Operating leases			5.80	%		5.25	%

12 Table of Contents

Cash flow information related to leases consists of the following:

	Three Month Ended March 31,
	For the Nine MonthsEnded September 30,
	2023		2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases *	$	-8,537	$	1219,~~601~~385
Right-of-use assets obtained in exchange for lease obligations:
Operating leases		27,~~494~~471		12,~~411~~194

**Future ~~Lease~~minimum lease payment ~~has~~under ~~been~~non-cancellable ~~waived~~lease byas ~~the~~of ~~landlord~~September ~~between~~30, ~~October 2022 and March~~ 2023 inare ~~response~~as ~~to government’s pandemic support package.~~ follows:

Future minimum lease payment under non-cancellable lease as of March 31, 2023 are as follows:

Ending September 30,	Operating Leases
Remaining of 2023	$	8,264
2024		33,054
2025		5,509
Total lease payments		46,827
Less: interest		(1,759	)
Present value of lease liabilities	$	45,068

Ending December 31,	OperatingLeases
Remaining of 2023	$	26,205
2024		34,940
2025		5,823
Total lease payments	$	66,968
Less: interest		(3,426	)
Present value of lease liabilities	$	63,542

NOTE 9 – INCOME TAXES

The Company accounts for income taxes under ASC 740, “Income Taxes”. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax basis of assets and liabilities and the tax rates in effect when these differences are expected to reverse. It also requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all the deferred tax assets will not be realized.

~~The~~12 ~~Company~~Table is subject to taxation in the United States and certain state jurisdictions. The provision for income taxes differs from the amounts which would be provided by applying the statutory federal income tax rate of 21% to the net loss before provision for income taxes. HKFW in Hong Kong are governed by the Inland Revenue Ordinance Tax Law of Hong Kong, and are generally subject to a profits tax at the rate of 16.5% on the estimated assessable profits. CBNB in the PRC is governed by the Income Tax Law of the PRC concerning the private enterprises, which are generally subject to tax at 25% on income reported in the statutory financial statements after appropriated adjustments. PRC also give tax discount to small enterprise whose annual taxable income exceeding 1 million but not exceeding 3 million.Contents

13The ~~Table~~Company is subject to taxation in the United States and certain state jurisdictions. The provision for income taxes differs from the amounts which would be provided by applying the statutory federal income tax rate of ~~Contents~~21% to the net loss before provision for income taxes. HKFW in Hong Kong are governed by the Inland Revenue Ordinance Tax Law of Hong Kong and are generally subject to a profits tax at the rate of 16.5% on the estimated assessable profits. CBNB in the PRC is governed by the Income Tax Law of the PRC concerning the private enterprises, which are generally subject to tax at 25% on income reported in the statutory financial statements after appropriate adjustments. PRC also gives tax discount to small enterprises whose annual taxable income are between one million to three million.

The Company’s income tax expense is mainly contributed by its subsidiary in PRC.

In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included currently in the gross income of the CFCs’ U.S. shareholder income. GILTI is the excess of the shareholder’s net CFC tested income over the net deemed tangible income return, which is currently defined as the excess of (1) 10 percent of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income. The Company has elected to recognize the tax on GILTI as a period expense in the period the tax is incurred. For the ~~three~~nine months ended ~~March~~September 3130, 2023 and 2022, no GILTI tax obligation existed, and the GILTI tax expense was $0.

~~There~~Income ~~was no income~~ tax provision for the ~~three~~nine months ended ~~March~~September 3130, 2023 and 2022 were $0 and $0, respectively.

Net deferred tax assets consist of the following components ~~as of~~:

	March 31,2023			December 31, 2022
	September 30,2023			December 31,2022
Deferred tax asset:
Net operating loss carry forwards	$	~~183~~198,~~004~~198		$	185,149
Valuation allowance		(~~183~~198,~~004~~198	)		(185,149	)
Net deferred tax asset	$	-		$	-

Due to the change in ownership provisions of the Income Tax laws of United States of America, net operating loss carry forwards of approximately $~~458~~500,~~700~~593, ~~which~~ will carry ~~indefinity~~indefinitely for federal income tax reporting purposes are subject to annual limitations. When a change in ownership occurs, net operating loss carry forwards may be limited as to use in future years. Tax filings for the Company for the years after 2018 are available for examination by state tax jurisdictions and federal tax purposes.

NOTE 10 – SEGMENT REPORTING

The Company operates in one industry segment, selling Acer truncatum bunge related health products through its wholly owned subsidiary in China. As of ~~March~~September 3130, 2023 and December 31, 2022, ~~the~~China subsidiary had amounts of $~~291~~84,~~922~~207 and $~~259~~99,~~713~~840, respectively, in total assets, excluding inter-company balances, and it ~~did~~generated ~~not~~$105,433 ~~revenue~~and $39,507 for the ~~three~~nine months ended ~~March~~September 3130, 2023 and 2022, respectively, in revenue. There was no revenue generated from inter-company transactions.

NOTE 11 13– SUBSEQUENT EVENT

The Company has evaluated all subsequent events through the date the unaudited consolidated financial statements were issued and determine that there were no subsequent events or transactions that require recognition or disclosures in the unaudited consolidated financial statements.

1413 Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

As used in this Form 10-Q, references to “MakingORG”,” the “Company,” “we,” “our” or “us” refer to MakingORG, Inc. and subsidiaries unless the context otherwise indicates.

Forward-Looking Statements

The following discussion should be read in conjunction with our financial statements, which are included elsewhere in this Form 10-Q (the “Report”). This Report contains forward-looking statements which relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested herein. We assume no obligation to update forward-looking statements, except as otherwise required under the applicable federal securities laws.

Plan of Operation

Our sole officer and director intends to sell Acer truncatum bunge related health product in the United States and PRC,. In the future, the Company may pursue business opportunities, acquisitions, business combinations, joint ventures, or other agreements with businesses in our industry or elsewhere. t this time, we have no plan, proposal, agreement, understanding or arrangement to acquire or merge with any specific business or company, and the Company has not identified any specific business or company for investigation and evaluation. No member of management or promoter of the Company has had any material discussions with any other company with respect to any acquisition of that company.

We will not restrict our search for another target company to any specific business, industry or geographical location, and the Company may participate in a business venture of virtually any kind or nature. The discussion of the proposed plan of operation under this caption and throughout this ~~Quarterly~~Annual Report is purposefully general and is not meant to be restrictive of the Company’s virtually unlimited discretion to search for and enter potential business opportunities.

15 Table of Contents

The following discussion should be read in conjunction with the unaudited interim financial statements contained in this Report and in conjunction with the Company’s Form 10-K/A filed on October 23, 2023. Results for interim periods may not be indicative of results for the full year.

Critical Accounting Policies and Estimates

There have been no material impacts to our accounting estimates as of ~~March~~September 3130, 2023 and December 31, 2022, or the results for the three and nine months ended ~~March~~September 3130, 2023 and 2022, from the COVID-19 pandemic. The federal COVID-19 Public Health Emergency declaration in the U.S. ended in May 2023, and COVID-19 restrictions have been lifted in many locations globally. We do not expect future material economic consequences from the COVID-19 pandemic.

Recent Accounting Pronouncements reflected in the ~~Condensed~~ Consolidated and Combined Financial Statements

In14 ~~September~~Table 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-04, Liabilities – Supplier Finance Programs (Subtopic 405-50). The ASU requires companies to disclose information about supplier finance programs, including key terms of the program, outstanding confirmed amounts as of the end of the period, a rollforward of such amounts during each annual period, and a description of where the amounts are presented. The new standard does not affect the recognition, measurement, or financial statement presentation of supplier finance obligations. The ASU is effective for fiscal years beginning after December 15, 2022, including interim periods, except for rollforward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted this guidance on January 1, 2023. See Note 17, “Supplemental Financial Information” for further information.Contents

In ~~October~~November ~~2021~~2023, the FASB issued ASU ~~No. 2021~~2023-0807, ~~Business~~Segment ~~Combinations~~Reporting (Topic ~~805~~280): Improvements ~~Accounting~~to ~~for~~Reportable ~~Contract~~Segment ~~Assets and Contract Liabilities from Contracts with Customers~~Disclosures. The ~~ASU~~amended guidance requires ~~companies~~incremental toreportable ~~apply~~segment ~~the definition of a performance obligation under ASC 606~~disclosures, ~~Revenue~~ ~~from~~primarily ~~Contracts~~about ~~with~~significant ~~Customers,~~segment toexpenses. ~~recognize~~The ~~and~~amendments ~~measure~~also ~~contract~~require ~~assets~~entities ~~and contract liabilities relating to contracts~~ with ~~customers acquired in~~ a ~~business~~single ~~combination.~~reportable ~~Prior~~segment to ~~the~~provide ~~adoption~~all ofdisclosures ~~this~~required ~~ASU,~~by anthese ~~acquirer generally recognized assets acquired and liabilities assumed in a business combination~~amendments, ~~including contract assets~~ and ~~contract~~all ~~liabilities~~existing ~~arising~~segment ~~from~~disclosures. ~~revenue~~The ~~contracts~~amendments ~~with~~will ~~customers,~~be atapplied ~~fair~~retrospectively ~~value~~to onall ~~the~~prior ~~acquisition~~periods ~~date.~~presented ~~The ASU results~~ in the ~~acquirer~~financial ~~recording~~statements ~~acquired contract assets~~ and ~~liabilities~~is oneffective ~~the~~for ~~same~~fiscal ~~basis~~years ~~that~~beginning ~~would~~after ~~have~~December ~~been~~15, ~~recorded~~2023, byand ~~the~~interim ~~acquiree~~periods ~~before~~in ~~the acquisition under ASC 606. The ASU is effective for~~ fiscal years beginning after December 15, ~~2022~~2024, with early adoption permitted. The Company ~~adopted~~is ~~this~~currently ~~guidance~~in onthe ~~January~~process 1,of ~~2023~~evaluating ~~using~~the aimpact ~~prospective~~this ~~method,~~amended ~~and~~guidance ~~the~~may ~~adoption did not~~ have ~~a material impact~~ on the ~~condensed~~footnotes to its consolidated financial statements.

The preparation of unaudited consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the unaudited consolidated financial statements, and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

As with most companies doing business in China, our operations were affected by the ongoing COVID-19 pandemic. The ultimate disruption that may result from the pandemic is uncertain, but it had material adverse impact on our financial positions, operations and cash flows. The federal COVID-19 Public Health Emergency declaration in the U.S. ended in May 2023, and COVID-19 restrictions have been lifted in many locations globally. We do not expect future material economic consequences from the COVID-19 pandemic.

16 Table of Contents

Results of Operations

For the three months ended ~~March~~September 3130, 2023 and 2022

	Three Months EndedMarch 31,
	Three MonthsEnded September 30,
	2023			2022			Change			Percent
Net Sales	$	-93,375		$	-39,507		$	-53,868		-	136	%
Cost of Sales		-(56,341	)		-(31,862	)		-(24,479	)	-	77	%
Gross Profit		-37,034			-7,645			-29,389		-	384	%
Operating expenses:
Selling, general and administrative		615,~~233~~826			2311,~~960~~583			~~(17~~4,~~727~~243	)		~~(74~~37	)%
Professional fees		96,~~110~~300			~~17,593~~300			(86,~~483~~000	)		~~(48~~2,000	)%
Total operating expenses		1522,~~343~~126			4111,~~553~~883			~~(26~~10,~~210~~243	)		~~(63~~86	)%
Loss from operations		(15,343	)		(41,553	)		26,210			(63	)%
Income (Loss) from operations		14,908			(4,238	)		19,146			(452	)%
Other income (expenses):
Interest income		4-			-15			4(15	)		(100	)%
Interest expense		(6,000	)		(6,000	)		-		-	-	%
Other income		1			2			(1	)		(50	)%
Other Income		-			121			(121	)		(100	)%
Total other expenses, net		(5,995	)		(5,998	)		3			0	%
Total other expenses		(6,000	)		(5,864	)		(136	)		2	%
Loss before income taxes		(21,338	)		(47,551	)		26,213			(55	)%
Net income (loss) before income taxes		8,908			(10,102	)		19,010			(188	)%
Income tax expense		-			-			-			-	%
Net loss	$	(21,338	)	$	(47,551	)	$	26,213			(55	)%
Net Income (loss)	$	8,908		$	(10,102	)	$	19,010			(188	)%

~~Net~~15 ~~sales,~~Table ~~cost~~ of ~~sales and gross profit~~Contents

~~For~~Net ~~the three months ended March 31, 2023 and 2022, no~~ sales ~~were occurred due to the COVID-19 pandemic and new regulations restricting our operations in PRC.~~

17The ~~Table~~Company’s consolidated net sales for the three months ended September 30, 2023 and 2022 were $93,375 and $39,507, respectively. Cost of ~~Contents~~sales for the three months ended September 30, 2023 and 2022 were $56,341 and $31,862, respectively, resulting in gross profits of $37,034 and $7,645 for the three months ended September 30, 2023 and 2022, respectively. The revenue increase of $53,868 or 136%, the cost of sales increase of $24,479 or 77%, and the gross profit increase of $29,389 or $384% was due to the increase in related party sales in PRC in the three months ended September 30, 2023 compared with the same period in 2022. The sales concentrate on one customer which consists of 100% of the revenue.

Total operating expenses

For the three months ended ~~March~~September 3130, 2023, total operating expenses were $1522,~~343~~126, which ~~mainly~~ consisted of professional ~~fee~~fees of $96,~~110~~300, ~~payroll~~China expenses including rent of $59,~~601~~459, ~~office~~salaries and other expenses of $~~632~~6,367. For the three months ended ~~March~~September 3130, 2022, total operating ~~expenses~~expense ~~were~~was $4111,~~553~~883, which consisted of professional ~~fee~~fees of $17300,~~593.~~ ~~Rent expenses in~~ China salary of $155,~~227~~886, office ~~and~~ other expenses ~~in China~~ of $85,~~733~~697. Total operating expenses ~~decreased~~increased $2610,~~210~~243, or 6386%, ~~for~~primarily as a result of the ~~three~~increase ~~months~~in ~~ended~~professional ~~March~~fees 31of $6,000, ~~2023~~and ~~compared~~China ~~with~~office ~~the~~and ~~three~~other ~~months~~expenses ~~ended~~increase ~~March~~of 31$4, ~~2022~~243.

Total other income (~~expense~~expenses)

For the three months ended ~~March~~September 3130, 2023, total other expenses ~~was~~were $56,~~995~~000, which ~~consists~~is ~~mainly~~related ofto ~~interest~~the ~~expense,~~convertible ~~offset by interest income of $4 and other income of $1~~note. For the three months ended ~~March~~September 3130, 2022, the Company had total other expenses ~~were~~of $5,~~998~~864, which isconsists ~~the~~primarily of interest expense of $6,000, offset by other income of $2121 and interest income of $15. Other expenses for the three months ended September 30, 2023 stayed the same level as the other expenses for the nine months ended September 30, 2022.

Net ~~income~~Income (loss)

For the three months ended ~~March~~September 3130, 2023, ~~net~~the ~~loss~~Company ~~was~~had ~~$21,338,~~ a ~~decrease~~net ofincome ~~loss~~ of $268,~~213~~908, ~~or 55%~~ compared with ~~the~~a net loss of $4710,~~551~~102 for the three months ended ~~March~~September 3130, 2022., ~~The~~a ~~decrease~~net increase of ~~loss~~income ~~was mainly due to lack~~ of ~~business activities for the three months ended March 31~~$19,010 ~~2023~~or ~~compared~~188%. toThe ~~the~~increase ~~three~~in ~~months~~net ~~ended~~income ~~March~~was ~~31, 2022~~ due to the ~~COVID-19~~reasons ~~pandemic~~stated ~~and regulations restricting business operating in China~~above.

Table of Contents

For the nine months ended September 30, 2023 and 2022

	Nine Months Ended September 30,
	2023			2022			Change			Percent
Net Sales	$	105,433		$	39,507		$	65,926			167	%
Cost of Sales		(62,479	)		(31,862	)		(30,617	)		96	%
Gross Profit		42,954			7,645			35,309			462	%

Operating expenses:
Selling, general and administrative		37,950			51,008			(13,058	)		(26	)%
Professional fees		28,149			31,845			(3,696	)		(12	)%
Total operating expenses		66,099			82,853			(16,754	)		(20	)%

Loss from operations		(23,145	)		(75,208	)		52,063			(69	)%

Other income (expenses):
Interest income		1			117			(116	)		(99	)%
Interest expense		(18,000	)		(18,000	)		-		-%
Other income		1			121			(120	)		(99	)%
Total other income (expenses)		(17,998	)		(17,762	)		(236	)		1	%

Loss before income taxes		(41,143	)		(92,970	)		51,827			(56	)%
Income tax expense		-			-			-			-

Net loss	$	(41,143	)	$	(92,970	)	$	51,827			(56	)%

Net sales

The Company’s consolidated sales increased by $65,926, or 167% to $105,433 for the nine months ended September 30, 2023 from $39,507 for the nine months ended September 30, 2022. Cost of sales increased $30,617 or 96% to $62,479 for the nine months ended September 30, 2023 from $31,862 for the nine months ended September 30, 2022. It resulted in a gross profit increased by $35,309 or 462% to $42,954 for the nine months ended September 31, 2023 from $7,645 for the nine months ended September 31, 2022. Gross profit increased due to the increase in related party sales in PRC after the Pandemic in 2023 compared to 2022. The sales concentrate on one customer, which consists of 100% of the revenue.

Total operating expenses

For the nine months ended September 30, 2023, total operating expenses were $66,099, which consisted of professional fees of $28,149, China salaries, office & other expenses of $21,758 and rent expenses of $15,211, and expenses of $982 in U.S. For the nine months ended September 30, 2022, total operating expenses were $82,853, which mainly consists of professional fees of $31,845, China salary of $17,272, office rent of $25,013 and other expenses of $8,723. Total operating expenses decreased $16,754, or 20%, which was a result of the decrease of $13,058 or 26% in rent and other expenses, and the decrease in professional fees paid of $3,696 or 12% for the nine months ended September 30, 2023 compared with the nine months ended September 30, 2022.

Total other income (expenses)

For the nine months ended September 30, 2023, the Company had other expenses of $17,998, which consists of interest expenses of $18,000, other income of $1 and interest income of $1. For the nine months ended September 30, 2022, the Company had other expenses of $17,762, which consists of interest income of $117, interest expenses of $18,000 and other income of $121. Other income/expenses were at a similar level for the nine months ended September 30, 2023, compared with the other income/expenses for the September 30, 2022. The decrease of total other expenses of $236, or 1% were caused by the decrease of interest income of $116, and the decrease of other income of $120 for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022.

Net Loss

For the nine months ended September 30, 2023, the Company had a net loss of $41,143, a decrease of net loss of $51,827 or 56% compared to the net loss of $92,970 for the nine months ended September 30, 2022. The decrease in net loss was due to the reasons stated above.

Table of Contents

Liquidity and Capital Resources

As of ~~March~~September 3130, 2023, ~~cash~~the ~~and~~company ~~cash~~had ~~equivalents and total assets were $27,129 and $129,424, respectively, compared to the~~ cash and cash ~~equivalent~~equivalents and total assets of $2343,~~852~~262 and $~~122~~99,~~087~~929, respectively ~~as of December 31, 2022~~. As of ~~March~~said 31date, ~~2023,~~the Company had total liabilities ~~were~~of $~~814~~807,~~642~~322, of which $200,000 was due to convertible note payable, $~~158,000 was interest payable and $~~387,918 was due to ~~our~~the sole officer and director as an unsecured, non-interest -bearing demand loan, $45,068 lease liabilities and $170,000 was interest payable. As of ~~December~~September 3130, 2022, the Company had cash and cash equivalents and total ~~liabilities~~assets of $~~786~~28,~~209~~583 and $129,636, respectively. As of ~~which~~said ~~$387~~date,~~918~~ ~~was~~the ~~due~~Company tohad ~~related~~total ~~party~~liabilities of $772,370, of which $200,000 was due to convertible note payable ~~and~~a $~~152~~387,~~000~~918 was due to the sole officer and director as an unsecured, non-interest-bearing ~~payable~~demand loan. As of ~~March~~September 3130, 2023, and December 31, 2022, the Company had negative working capital amount of $~~483~~493,~~884~~452 and $458,621, respectively.

Other than an oral agreement with ~~Mrs~~Ms. Cui to fund the expenses of the Company, we currently have no agreements, arrangements or understandings with financial institution or any person to obtain funds through bank loans, lines of credit or any other sources. Since the Company has no such arrangements or plans currently in effect, its inability to raise funds for the above purposes will have a severe negative impact on its ability to remain a viable company.

18 Table of Contents

Cash Flows from Operating Activities

For the ~~three~~nine months ended ~~March~~September 3130, 2023, net cash flows provided by operating activities was $320,~~554~~226, ~~resulted~~resulting from a net loss of $2141,~~338~~143, ~~increased~~an byincrease ~~$32,649~~ in the ~~changes~~change ofin accounts receivable, ~~decreased~~of by $3631,~~160 in~~785, ~~amortization~~an ofincrease ~~right-of-use~~in ofadvances ~~assets,~~to ~~$6,000~~vendor inand ~~changes~~others inof $26,723, interest payable, of $318,~~654~~000 inand ~~changes~~decrease inof ~~customer~~amortization ~~deposit~~of ~~and~~right-of-use assets of $3420,~~322~~372, inoffset ~~lease~~by the increase of accrued liabilities~~, decreased~~ byof $1512,~~573~~638 inand ~~changes~~lease inliability ~~accrued~~of ~~liabilities~~$17,871. For the ~~three~~nine months ended ~~March~~September 3130, 2022, net cash flows used in operating activities was $2976,~~450~~461, ~~resulted~~resulting from a net loss of $4792,~~551~~970, ~~increased~~an increase of loss caused by ~~$6,000~~changes ofin ~~interest~~accounts ~~expense,~~receivable of $1333,~~215~~850, amortization of ~~accrued~~right-of-use ~~liabilities~~of ~~and~~assets of $1,~~114~~058 and accrued liability of ~~prepaid~~$586, ~~expenses.~~offset ~~The~~by ~~net~~the increase of ~~cash~~advances ~~flows~~to vendor and others of $33,~~004~~907, orinterest ~~112%~~payable inof ~~operating~~$18,000 ~~activities~~and inlease ~~three~~liabilities ~~months~~of ~~ended~~$96. ~~March~~The ~~31,~~net ~~2023~~cash ~~compared~~flow toprovided ~~2022~~by ~~was~~operating ~~mainly~~activities ~~due~~for tothe ~~restrictions~~nine onmonths ~~our~~ended ~~business~~September ~~during~~30, ~~COVID-19~~2023 inwas ~~the~~$20,226, ~~first~~an ~~quarter~~increase of ~~2023~~$96,687 ~~compared~~from tooutflow of $76,461 for the ~~same~~nine ~~period~~months inended September 30, 2022.

Cash Flows from Investing Activities

For the ~~three~~nine months ended ~~March~~September 3130, 2023 and 2022, ~~the~~there ~~Company~~was ~~did~~no ~~not have any~~ cash flow ~~from~~used in investing activities.

Cash Flows from Financing Activities

~~The~~For ~~Company~~the ~~financed~~nine ~~its~~months ~~operations~~ended ~~primarily~~September ~~from~~30, ~~the~~2023 and 2022, advances from the Company’s sole officer and director. ~~For~~provided ~~the~~were ~~three~~$0 ~~months ended March 31, 2023~~ and ~~March 31~~$1, ~~2022~~500, ~~there was no cash flow from financing activity~~respectively.

Going Concern Consideration

AsThese ofconsolidated ~~March~~financial ~~31,~~statements ~~2023,~~have ~~the~~been ~~Company~~prepared ~~had~~on ana ~~accumulated~~going ~~deficit~~concern ~~of $1~~basis,~~300,000~~ ~~and~~which ~~its~~assumes ~~current~~the ~~liabilities~~Company ~~exceeded~~will ~~its~~continue ~~current~~to realize its assets, ~~resulting~~and indischarge aits ~~negative~~liabilities ~~working~~in ~~capital~~the normal course of ~~$483,884~~business. The ~~Company’s~~continuation ~~ability~~of tothe ~~continue~~Company as a going concern is dependent onupon the continued financial support from its shareholders, the ability of the Company to ~~raise~~repay ~~additional~~its ~~capital~~debt obligations, to obtain necessary equity financing to continue operations, and the attainment of profitable operations. ~~The~~Management anticipates that the Company’s ~~unaudited~~will ~~condensed~~be ~~consolidated~~dependent, ~~financial~~in ~~statements~~the donear ~~not~~future, ~~include~~on ~~any~~additional ~~adjustments~~investment ~~relating~~capital to ~~the~~fund ~~recoverability~~operating ~~and~~expenses. ~~classification~~The Company may seek additional funding through additional issuance of ~~reported~~common ~~asset~~stock ~~amounts~~and/or borrowings from financial institutions or the ~~amount~~majority ~~and~~shareholder ~~classification~~to support its normal business operations. In light of ~~liabilities~~management’s ~~that~~efforts, ~~might~~there beare ~~necessary~~no ~~should~~assurances that the Company will be ~~unable~~successful toin this or any of its endeavors or become financially viable and continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

~~These~~The ~~unaudited~~Company ~~condensed~~had ~~consolidated~~net ~~financial~~loss ~~statements~~of ~~have been prepared on a going concern basis~~$41,143 ~~which~~for ~~assumes~~ the ~~Company~~nine ~~will~~months ~~continue~~ended toSeptember ~~realize~~30, ~~its~~2023, ~~assets~~a ~~and~~decrease ~~discharge~~of ~~its~~loss ~~liabilities~~of in$51,827 from the ~~normal~~net ~~course~~loss of ~~business.~~$92,970 ~~The~~for ~~continuation of~~ the ~~Company~~nine asmonths aended ~~going~~September ~~concern~~30, is2022, ~~dependent~~In ~~upon~~addition, the ~~continued~~Company ~~financial~~had ~~support~~an ~~from~~accumulated ~~its~~deficit ~~shareholders~~of $1,319,805 ~~the~~as ~~ability~~ of ~~the~~September ~~Company~~30, to2023, ~~repay~~even ~~its~~though ~~debt~~it ~~obligations,~~generated topositive ~~obtain~~cash ~~necessary~~flow ~~equity~~of ~~financing~~$20,226 tofrom ~~continue~~operating ~~operations,~~activities ~~and~~for the ~~attainment~~nine ofmonths ~~profitable~~ended ~~operations.~~September ~~Management~~30, ~~anticipates~~2023. ~~that~~These ~~the~~factors ~~Company~~raise ~~will~~substantial bedoubt ~~dependent,~~about ~~for~~ the ~~near~~Company’s ~~future,~~ability onto ~~additional~~continue ~~investment~~as ~~capital~~a togoing ~~fund operating expenses~~concern. The Company’s ~~may~~ability ~~seek~~to ~~additional~~continue ~~funding~~as ~~through~~a ~~additional~~going ~~issuance~~concern ofis ~~common~~dependent ~~stock~~on ~~and/or~~its ~~borrowings~~ability ~~from financial institutions or the majority shareholder~~ to ~~support~~raise ~~its~~additional ~~normal business operations~~capital. InThe ~~light of management~~Company’s ~~efforts,~~consolidated ~~there~~financial ~~are~~statements nodo ~~assurances~~not ~~that~~include ~~the~~any ~~Company~~adjustments ~~will~~relating beto ~~successful~~the inrecoverability ~~this~~and orclassification ~~any~~ of ~~its~~reported ~~endeavors~~asset amounts or ~~become~~the ~~financially~~amount ~~viable~~ and ~~continue~~classification asof aliabilities ~~going~~that ~~concern.~~might ~~The~~be ~~financial~~necessary ~~statements~~should dothe ~~not~~Company ~~include~~be ~~any~~unable ~~adjustments~~to ~~that~~continue ~~might~~as ~~result~~a ~~from~~going ~~the outcome of this uncertainty~~concern.

1918 Table of Contents

Convertible Note Payable

On September 1, 2016, the Company entered into a Convertible Note Agreement in the principal amount of $200,000 with an unrelated party. The note bears interest at 12% per annum and the holder is able to convert all unpaid interest and principal into common shares at $3.50 per share. The note matures on September 1, 2018. The Company recognized a discount on the note of $38,857 at the agreement date. The interest expense was due every six months commencing on March 1, 2017 until the principal amount of this convertible note is paid in full.

On September 1, 2018, the Company entered into an Amended and Restated 12% Convertible Promissory Note. Pursuant to an Amended and Restated 12% Convertible Promissory Note, both parties agreed to extend a Convertible Note Agreement to September 1, 2019 with no additional consideration. The Company recognized a discount on the note of $40,000 at the amended agreement date.

On September 1, 2019, the Company entered into an amended and restated 12% convertible promissory note. Pursuant to the amended convertible promissory note, both parties agreed to extend the convertible note agreement to September 1, 2020 with no additional consideration. The Company recognized a discount on the note of $54,400 at the amended agreement date. Since the conversion feature of conventional convertible debt provides for a rate of conversion that is below market value, this feature is characterized as a beneficial conversion feature (“BCF”). A BCF is recorded by the Company as a debt discount pursuant to ASC Topic 470-20 “Debt with Conversion and Other Options.” In those circumstances, the convertible debt is recorded net of the discount related to the BCF and the Company amortizes the discount to interest expense over the life of the debt using the effective interest method.

On September 1, 2020, the Company entered into an amended and restated 12% convertible promissory note. Pursuant to the amended convertible promissory note, both parties agreed to extend the convertible note agreement to September 1, 2022 with no additional consideration. The Company recognized a discount on the note of $0 at the amended agreement date.

On September 1, 2022, the Company entered into an amended and restated 12% convertible promissory note. Pursuant to the amended convertible promissory note, both parties agreed to extend the convertible note agreement to September 1, 2024 with no additional consideration.

~~For~~The ~~the three months ended March 31, 2023 and 2022, the~~ Company recognized interest expenses related to the convertible note of $618,000 and $618,000, respectively, for the nine months ended September 30, 2023 and 2022. As of ~~March~~September 3130, 2023, and December 31, 2022, net ~~balances~~balance of the convertible note ~~were~~amounted to $200,000 and $200,000, respectively.

Operating Lease

The Company has operating lease for its office in China. Rental expenses for the three months ended ~~March~~September 3130, 2023 and 2022 were $29,~~801~~459 and $15858,~~227,~~ respectively. As of ~~March~~September 3130, 2023, the remaining lease term was 2317 months. Total future minimum annual lease payments under operating lease were as follows:

Ending March 31,	OperatingLeases
Ending September 30,	OperatingLeases
Remaining of 2023	$	268,~~205~~264
2024		3433,~~940~~054
2025		5,~~823~~509
Total lease payments	$	6646,~~968~~827
		(3,426	)
Less: interest		(1,759	)
Total lease payments	$	6345,~~542~~068

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

20Item ~~Table~~3. ofQuantitative ~~Contents~~and Qualitative Disclosure About Market Risk

~~Item~~As ~~3. Quantitative~~a ~~and~~smaller ~~Qualitative~~reporting ~~Disclosure~~company, ~~About~~we ~~Market~~are ~~Risk~~not required to provide the information required by this item.

As a smaller company, we are not required to provide the information required by this item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our management, including our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act as of the end of the period covered by this report. Our management does not expect that our disclosure controls and procedures will prevent all error and all fraud. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

Based on that evaluation, as of ~~March~~September 3130, 2023, ~~our~~the chief executive officer and chief financial officer concluded that our disclosure controls and procedures were ineffective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes that have affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) under the Exchange Act) during the period covered by this report.

2119 Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

Management is not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this Quarterly Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us or our properties.

Item 1A. Risk Factors.

As a smaller reporting company, we are not required to provide the information required by this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

None.

Purchases of equity securities by the issuer and affiliated purchasers

None.

Use of Proceeds

None

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

2220 Table of Contents

Item 6. Exhibits

31.1	~~Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act~~	Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
32.1	~~Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act~~	Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act
32.2		Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

Table of Contents

23 Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MakingORG, Inc.
Dated: July 5, 2024	By:	/s/ Juanzi Cui
Dated: July 26, 2024	By:	/s/ Juanzi Cui
	Name:	Juanzi CuiPresident, Chief Executive Officer and Chief Financial Officer(principal executive officer and principalfinancial and accounting officer)
		Name: Juanzi CuiPresident, Chief Executive Officer and Chief Financial Officer(principal executive officer and principalfinancial and accounting officer)

2422

Filing Compare · MAKINGORG, INC.